HEMO
LSE · EquityHemogenyx Pharmaceuticals Plc
GB Healthcare Biotechnology
- Latest week
- 29 May 2026
- Close
- 698.000000
- Fair value
- 633.567307
- Expectation
- Negative 37.99%
Chart Summary
Key Points
- Week Ending
- 29 May 2026
- Latest Close
- 698.00
- 12-Week Change
- -39.04%
- Trend Signal
- Inactive
- Expectation
- Negative 37.99%
- Signal Weeks
- 3 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -3.45
- Market Dynamics
- -1.09
Over the latest 12 completed weeks ending 2026-05-29, HEMO fell 39.04%, moving from 1,145.00 to 698.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 3 of the last 12 weeks. Relative Strength is -3.45 and has softened across the 12-week window. Market Dynamics is -1.09 on the latest week. Expectation is negative at 37.99%.